Rank | Gene Set | Z-score |
---|---|---|
1 | detection of bacterium (GO:0016045) | 5.22554412 |
2 | detection of other organism (GO:0098543) | 5.16051943 |
3 | keratinization (GO:0031424) | 5.14266468 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.05058410 |
5 | negative regulation of cell killing (GO:0031342) | 4.86026857 |
6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.86026857 |
7 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.48163998 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.44883148 |
9 | modulation by symbiont of host defense response (GO:0052031) | 4.44883148 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.44883148 |
11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.44883148 |
12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.44883148 |
13 | modulation by symbiont of host immune response (GO:0052553) | 4.44883148 |
14 | neuron cell-cell adhesion (GO:0007158) | 4.19165991 |
15 | leukocyte aggregation (GO:0070486) | 4.08077701 |
16 | detection of external biotic stimulus (GO:0098581) | 4.03292008 |
17 | macrophage activation involved in immune response (GO:0002281) | 3.86850333 |
18 | neutrophil activation involved in immune response (GO:0002283) | 3.85066326 |
19 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.80667041 |
20 | response to peptidoglycan (GO:0032494) | 3.67441439 |
21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.64222440 |
22 | response to muramyl dipeptide (GO:0032495) | 3.56283679 |
23 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.51662043 |
24 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.49713575 |
25 | cellular extravasation (GO:0045123) | 3.49332742 |
26 | detection of biotic stimulus (GO:0009595) | 3.49030056 |
27 | postsynaptic membrane organization (GO:0001941) | 3.44318773 |
28 | synaptic vesicle exocytosis (GO:0016079) | 3.43588800 |
29 | vocalization behavior (GO:0071625) | 3.36185923 |
30 | response to type I interferon (GO:0034340) | 3.30258831 |
31 | type I interferon signaling pathway (GO:0060337) | 3.29161167 |
32 | cellular response to type I interferon (GO:0071357) | 3.29161167 |
33 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.26599606 |
34 | mannose metabolic process (GO:0006013) | 3.23671905 |
35 | negative regulation of interleukin-12 production (GO:0032695) | 3.22811587 |
36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.22179100 |
37 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21397728 |
38 | germinal center formation (GO:0002467) | 3.21071144 |
39 | exploration behavior (GO:0035640) | 3.18425567 |
40 | regulation of mast cell degranulation (GO:0043304) | 3.15900119 |
41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11948243 |
42 | detection of molecule of bacterial origin (GO:0032490) | 3.10058030 |
43 | establishment of skin barrier (GO:0061436) | 3.09547162 |
44 | regulation of T cell tolerance induction (GO:0002664) | 3.07120972 |
45 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.06976066 |
46 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.05914014 |
47 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.04831602 |
48 | immunoglobulin mediated immune response (GO:0016064) | 3.04760418 |
49 | regulation of gamma-delta T cell activation (GO:0046643) | 3.04381450 |
50 | regulation of B cell differentiation (GO:0045577) | 3.03404515 |
51 | positive regulation of humoral immune response (GO:0002922) | 3.02352075 |
52 | positive thymic T cell selection (GO:0045059) | 3.01591271 |
53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.01062197 |
54 | positive T cell selection (GO:0043368) | 3.00293160 |
55 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.99842047 |
56 | positive regulation of B cell differentiation (GO:0045579) | 2.99401648 |
57 | tolerance induction (GO:0002507) | 2.98936717 |
58 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.97477488 |
59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.97452835 |
60 | response to host immune response (GO:0052572) | 2.97452835 |
61 | defense response to protozoan (GO:0042832) | 2.97206977 |
62 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.96404575 |
63 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96111225 |
64 | response to host (GO:0075136) | 2.96111225 |
65 | response to host defenses (GO:0052200) | 2.96111225 |
66 | neutrophil activation (GO:0042119) | 2.94551073 |
67 | regulation of leukocyte degranulation (GO:0043300) | 2.92861990 |
68 | myeloid cell activation involved in immune response (GO:0002275) | 2.90528508 |
69 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.87664143 |
70 | layer formation in cerebral cortex (GO:0021819) | 2.86535023 |
71 | protein localization to synapse (GO:0035418) | 2.86346451 |
72 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.84206426 |
73 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84156014 |
74 | regulation of regulatory T cell differentiation (GO:0045589) | 2.83138141 |
75 | glutamate secretion (GO:0014047) | 2.82349045 |
76 | regulation of cellular amide metabolic process (GO:0034248) | 2.82183173 |
77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.80980844 |
78 | negative regulation of interleukin-6 production (GO:0032715) | 2.79481769 |
79 | regulation of water loss via skin (GO:0033561) | 2.78977808 |
80 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.77858944 |
81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.77816999 |
82 | regulation of tolerance induction (GO:0002643) | 2.76944859 |
83 | granulocyte activation (GO:0036230) | 2.76798668 |
84 | dendritic cell migration (GO:0036336) | 2.76378378 |
85 | response to interleukin-15 (GO:0070672) | 2.75033039 |
86 | cellular response to interleukin-15 (GO:0071350) | 2.74450128 |
87 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.73237005 |
88 | response to protozoan (GO:0001562) | 2.73100178 |
89 | defense response to Gram-negative bacterium (GO:0050829) | 2.72930951 |
90 | respiratory burst (GO:0045730) | 2.72751595 |
91 | neuron recognition (GO:0008038) | 2.72239045 |
92 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.72175861 |
93 | microglial cell activation (GO:0001774) | 2.71336972 |
94 | macrophage activation (GO:0042116) | 2.70877505 |
95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70478312 |
96 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.70210818 |
97 | regulation of vesicle fusion (GO:0031338) | 2.66279358 |
98 | response to pheromone (GO:0019236) | 2.65902782 |
99 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.65169577 |
100 | negative regulation of phagocytosis (GO:0050765) | 2.65098669 |
101 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.63992448 |
102 | negative T cell selection (GO:0043383) | 2.63850650 |
103 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.63848583 |
104 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63632275 |
105 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.61414646 |
106 | negative regulation of innate immune response (GO:0045824) | 2.61260020 |
107 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.61165198 |
108 | positive regulation of synapse assembly (GO:0051965) | 2.61029002 |
109 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.60654701 |
110 | locomotory exploration behavior (GO:0035641) | 2.59668232 |
111 | presynaptic membrane assembly (GO:0097105) | 2.59496396 |
112 | glutamate receptor signaling pathway (GO:0007215) | 2.59369339 |
113 | behavioral response to nicotine (GO:0035095) | 2.59085786 |
114 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.57933189 |
115 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.57508511 |
116 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.55849564 |
117 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.55671691 |
118 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.53222027 |
119 | negative thymic T cell selection (GO:0045060) | 2.53153306 |
120 | synaptic vesicle endocytosis (GO:0048488) | 2.50605418 |
121 | response to histamine (GO:0034776) | 2.49355214 |
122 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.48571082 |
123 | negative regulation of microtubule polymerization (GO:0031115) | 2.47911651 |
124 | cell migration in hindbrain (GO:0021535) | 2.47442522 |
125 | opioid receptor signaling pathway (GO:0038003) | 2.47132684 |
126 | proline transport (GO:0015824) | 2.45530906 |
127 | histone H3-K4 trimethylation (GO:0080182) | 2.42101166 |
128 | synapse assembly (GO:0007416) | 2.40112099 |
129 | neurotransmitter secretion (GO:0007269) | 2.40039455 |
130 | mature B cell differentiation (GO:0002335) | 2.38948770 |
131 | axon extension (GO:0048675) | 2.38649993 |
132 | NIK/NF-kappaB signaling (GO:0038061) | 2.37287519 |
133 | T cell selection (GO:0045058) | 2.37056873 |
134 | dendritic spine morphogenesis (GO:0060997) | 2.33903430 |
135 | thymic T cell selection (GO:0045061) | 2.33002452 |
136 | axonal fasciculation (GO:0007413) | 2.30285736 |
137 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.29393854 |
138 | positive regulation of fibroblast migration (GO:0010763) | 2.28213281 |
139 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.27719475 |
140 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.25568835 |
141 | regulation of synaptic vesicle transport (GO:1902803) | 2.25485109 |
142 | synaptic vesicle maturation (GO:0016188) | 2.25285546 |
143 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.24750804 |
144 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.24750804 |
145 | activated T cell proliferation (GO:0050798) | 2.23589798 |
146 | negative regulation of T cell mediated immunity (GO:0002710) | 2.23321705 |
147 | synaptic transmission, glutamatergic (GO:0035249) | 2.22469495 |
148 | regulation of postsynaptic membrane potential (GO:0060078) | 2.22017784 |
149 | dendrite morphogenesis (GO:0048813) | 2.21396066 |
150 | prepulse inhibition (GO:0060134) | 2.20285402 |
151 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.19449884 |
152 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.18130144 |
153 | presynaptic membrane organization (GO:0097090) | 2.16456849 |
154 | T cell migration (GO:0072678) | 2.16040673 |
155 | synaptic vesicle transport (GO:0048489) | 2.15612264 |
156 | establishment of synaptic vesicle localization (GO:0097480) | 2.15612264 |
157 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.14846989 |
158 | dopamine biosynthetic process (GO:0042416) | 2.13859034 |
159 | regulation of dopamine secretion (GO:0014059) | 2.13354012 |
160 | membrane hyperpolarization (GO:0060081) | 2.12883180 |
161 | B cell receptor signaling pathway (GO:0050853) | 2.12033443 |
162 | positive regulation of vesicle fusion (GO:0031340) | 2.11938347 |
163 | regulation of synapse structural plasticity (GO:0051823) | 2.11599030 |
164 | neuron-neuron synaptic transmission (GO:0007270) | 2.08944427 |
165 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.06499971 |
166 | positive regulation of filopodium assembly (GO:0051491) | 2.05990201 |
167 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.05692648 |
168 | regulation of synapse assembly (GO:0051963) | 2.05655617 |
169 | clathrin coat assembly (GO:0048268) | 2.04986975 |
170 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.04931347 |
171 | synaptic transmission, cholinergic (GO:0007271) | 2.03573374 |
172 | regulation of filopodium assembly (GO:0051489) | 2.03255902 |
173 | T cell homeostasis (GO:0043029) | 2.02972029 |
174 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.02565714 |
175 | membrane depolarization (GO:0051899) | 2.01758290 |
176 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.01709988 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.72579142 |
2 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.89793893 |
3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.68708990 |
4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.67419311 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 2.65927654 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58701324 |
7 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.54592996 |
8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53617162 |
9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.49605656 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.44846032 |
11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.42271301 |
12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.42196002 |
13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41495548 |
14 | MAF_26560356_Chip-Seq_TH1_Human | 2.35785837 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33415746 |
16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.21631430 |
17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20542777 |
18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19026752 |
19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.17850770 |
20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16010732 |
21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.14493024 |
22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.14407829 |
23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.14001363 |
24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.13761017 |
25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.13761017 |
26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13000348 |
27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.11060281 |
28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.10079727 |
29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.10071065 |
30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.10055657 |
31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08242061 |
32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.05869318 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.05539208 |
34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.05175072 |
35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.03273298 |
36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.03211310 |
37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01373996 |
38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.00232580 |
39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.99919187 |
40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99461419 |
41 | MYB_26560356_Chip-Seq_TH2_Human | 1.95899830 |
42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.94542275 |
43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94188983 |
44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.92376434 |
45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.92369968 |
46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.89916926 |
47 | MAF_26560356_Chip-Seq_TH2_Human | 1.88465827 |
48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88230498 |
49 | MYB_26560356_Chip-Seq_TH1_Human | 1.84972420 |
50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.84957185 |
51 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.82424176 |
52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77367162 |
53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73469079 |
54 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68157769 |
55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65026532 |
56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63622180 |
57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62992609 |
58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.59580333 |
59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58728047 |
60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.58482400 |
61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56911024 |
62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55425181 |
63 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.50436945 |
64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50028968 |
65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49508846 |
66 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49223805 |
67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46535309 |
68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45000293 |
69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.44972964 |
70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.39839262 |
71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37958749 |
72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36759473 |
73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36305142 |
74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34488775 |
75 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.34173702 |
76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34012166 |
77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.32099169 |
78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31615202 |
79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.30958909 |
80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30213975 |
81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30009977 |
82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29153104 |
83 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.27434589 |
84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26656464 |
85 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24856878 |
86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24001569 |
87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23441281 |
88 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.22887736 |
89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21104736 |
90 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20817824 |
91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20332366 |
92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19748278 |
93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19436693 |
94 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19313580 |
95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19215179 |
96 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19140655 |
97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19011342 |
98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18237982 |
99 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18230435 |
100 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18077803 |
101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18072874 |
102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17603314 |
103 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16987808 |
104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16647376 |
105 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16280566 |
106 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15742386 |
107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15619382 |
108 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13666997 |
109 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13629879 |
110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13584150 |
111 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12706708 |
112 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11379409 |
113 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11360971 |
114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11069076 |
115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10823463 |
116 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09049151 |
117 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08711018 |
118 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08423373 |
119 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08332975 |
120 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08213139 |
121 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07528425 |
122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06932827 |
123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04002128 |
124 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.03863593 |
125 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.02868278 |
126 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02854589 |
127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02171913 |
128 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01772971 |
129 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00702214 |
130 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00446482 |
131 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99746769 |
132 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.99717014 |
133 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99269102 |
134 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98502554 |
135 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98350288 |
136 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98259861 |
137 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98259861 |
138 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97944591 |
139 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97812894 |
140 | P68_20966046_ChIP-Seq_HELA_Human | 0.97741278 |
141 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97612780 |
142 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97385664 |
143 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97326579 |
144 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96887418 |
145 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96355809 |
146 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95844294 |
147 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.95292665 |
148 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95222660 |
149 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93286908 |
150 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93230890 |
151 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93080795 |
152 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91993592 |
153 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91993592 |
154 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91682433 |
155 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91299806 |
156 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91157120 |
157 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90023716 |
158 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88479614 |
159 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88182560 |
160 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88181537 |
161 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87285546 |
162 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.86944859 |
163 | AR_19668381_ChIP-Seq_PC3_Human | 0.86406684 |
164 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85940603 |
165 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84033407 |
166 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.83835859 |
167 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83739578 |
168 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83410662 |
169 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83250283 |
170 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83203119 |
171 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82640811 |
172 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82401295 |
173 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82379539 |
174 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82173322 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.06156553 |
2 | MP0003880_abnormal_central_pattern | 3.47985892 |
3 | MP0003724_increased_susceptibility_to | 3.03771429 |
4 | MP0001188_hyperpigmentation | 2.93113079 |
5 | MP0003191_abnormal_cellular_cholesterol | 2.78285657 |
6 | MP0001968_abnormal_touch/_nociception | 2.69678170 |
7 | MP0003635_abnormal_synaptic_transmissio | 2.61747436 |
8 | MP0008260_abnormal_autophagy | 2.58602740 |
9 | MP0005423_abnormal_somatic_nervous | 2.52187427 |
10 | MP0000569_abnormal_digit_pigmentation | 2.42794092 |
11 | MP0002735_abnormal_chemical_nociception | 2.27868860 |
12 | MP0002736_abnormal_nociception_after | 2.25343122 |
13 | MP0006276_abnormal_autonomic_nervous | 2.09802201 |
14 | MP0009745_abnormal_behavioral_response | 2.07762928 |
15 | MP0003303_peritoneal_inflammation | 2.07151529 |
16 | MP0005174_abnormal_tail_pigmentation | 2.00795413 |
17 | MP0005451_abnormal_body_composition | 1.92401401 |
18 | MP0002064_seizures | 1.89176698 |
19 | MP0004510_myositis | 1.85442312 |
20 | MP0002405_respiratory_system_inflammati | 1.84800149 |
21 | MP0002733_abnormal_thermal_nociception | 1.82606809 |
22 | MP0003705_abnormal_hypodermis_morpholog | 1.82216312 |
23 | MP0001533_abnormal_skeleton_physiology | 1.82145188 |
24 | MP0002063_abnormal_learning/memory/cond | 1.81402332 |
25 | MP0001486_abnormal_startle_reflex | 1.77402015 |
26 | MP0009333_abnormal_splenocyte_physiolog | 1.73950381 |
27 | MP0002572_abnormal_emotion/affect_behav | 1.72795837 |
28 | MP0002734_abnormal_mechanical_nocicepti | 1.70406779 |
29 | MP0001440_abnormal_grooming_behavior | 1.69311364 |
30 | MP0001970_abnormal_pain_threshold | 1.69109895 |
31 | MP0002396_abnormal_hematopoietic_system | 1.69013535 |
32 | MP0005275_abnormal_skin_tensile | 1.67807825 |
33 | MP0004742_abnormal_vestibular_system | 1.66179207 |
34 | MP0005058_abnormal_lysosome_morphology | 1.66058027 |
35 | MP0009046_muscle_twitch | 1.64920008 |
36 | MP0004858_abnormal_nervous_system | 1.64286113 |
37 | MP0001501_abnormal_sleep_pattern | 1.62220240 |
38 | MP0010234_abnormal_vibrissa_follicle | 1.61178095 |
39 | MP0002184_abnormal_innervation | 1.60450756 |
40 | MP0005501_abnormal_skin_physiology | 1.59391852 |
41 | MP0005671_abnormal_response_to | 1.59066401 |
42 | MP0003453_abnormal_keratinocyte_physiol | 1.57566193 |
43 | MP0005387_immune_system_phenotype | 1.56869199 |
44 | MP0001790_abnormal_immune_system | 1.56869199 |
45 | MP0000015_abnormal_ear_pigmentation | 1.53939319 |
46 | MP0003300_gastrointestinal_ulcer | 1.51008541 |
47 | MP0000778_abnormal_nervous_system | 1.50955441 |
48 | MP0001851_eye_inflammation | 1.48948635 |
49 | MP0002722_abnormal_immune_system | 1.48580071 |
50 | MP0001835_abnormal_antigen_presentation | 1.47972950 |
51 | MP0001845_abnormal_inflammatory_respons | 1.46537599 |
52 | MP0001800_abnormal_humoral_immune | 1.46232954 |
53 | MP0002067_abnormal_sensory_capabilities | 1.46002018 |
54 | MP0000858_altered_metastatic_potential | 1.45839695 |
55 | MP0000689_abnormal_spleen_morphology | 1.44188201 |
56 | MP0003436_decreased_susceptibility_to | 1.43965982 |
57 | MP0005310_abnormal_salivary_gland | 1.43195882 |
58 | MP0002557_abnormal_social/conspecific_i | 1.43003584 |
59 | MP0009278_abnormal_bone_marrow | 1.40906997 |
60 | MP0003828_pulmonary_edema | 1.39150550 |
61 | MP0003763_abnormal_thymus_physiology | 1.39049960 |
62 | MP0001986_abnormal_taste_sensitivity | 1.38408187 |
63 | MP0001905_abnormal_dopamine_level | 1.38267112 |
64 | MP0003787_abnormal_imprinting | 1.36058378 |
65 | MP0002429_abnormal_blood_cell | 1.35677669 |
66 | MP0003566_abnormal_cell_adhesion | 1.35017392 |
67 | MP0005409_darkened_coat_color | 1.34484455 |
68 | MP0008961_abnormal_basal_metabolism | 1.32799887 |
69 | MP0003866_abnormal_defecation | 1.32331644 |
70 | MP0002998_abnormal_bone_remodeling | 1.31894432 |
71 | MP0005000_abnormal_immune_tolerance | 1.30981311 |
72 | MP0002272_abnormal_nervous_system | 1.30227488 |
73 | MP0001348_abnormal_lacrimal_gland | 1.25912708 |
74 | MP0002933_joint_inflammation | 1.23326695 |
75 | MP0003172_abnormal_lysosome_physiology | 1.22857260 |
76 | MP0001545_abnormal_hematopoietic_system | 1.22570817 |
77 | MP0005397_hematopoietic_system_phenotyp | 1.22570817 |
78 | MP0003122_maternal_imprinting | 1.22491315 |
79 | MP0002420_abnormal_adaptive_immunity | 1.21680547 |
80 | MP0001819_abnormal_immune_cell | 1.21629159 |
81 | MP0004270_analgesia | 1.21526579 |
82 | MP0002452_abnormal_antigen_presenting | 1.19783981 |
83 | MP0009785_altered_susceptibility_to | 1.18646877 |
84 | MP0003183_abnormal_peptide_metabolism | 1.18515362 |
85 | MP0002723_abnormal_immune_serum | 1.17532779 |
86 | MP0002132_abnormal_respiratory_system | 1.15488833 |
87 | MP0008569_lethality_at_weaning | 1.13823969 |
88 | MP0005645_abnormal_hypothalamus_physiol | 1.12504384 |
89 | MP0008469_abnormal_protein_level | 1.11662302 |
90 | MP0004811_abnormal_neuron_physiology | 1.09879578 |
91 | MP0001216_abnormal_epidermal_layer | 1.09643372 |
92 | MP0000685_abnormal_immune_system | 1.07845232 |
93 | MP0005386_behavior/neurological_phenoty | 1.07080451 |
94 | MP0004924_abnormal_behavior | 1.07080451 |
95 | MP0003279_aneurysm | 1.06762564 |
96 | MP0000579_abnormal_nail_morphology | 1.05975235 |
97 | MP0001958_emphysema | 1.05464908 |
98 | MP0004947_skin_inflammation | 1.05352421 |
99 | MP0005076_abnormal_cell_differentiation | 1.05256390 |
100 | MP0002102_abnormal_ear_morphology | 1.04578661 |
101 | MP0003045_fibrosis | 1.04265100 |
102 | MP0009840_abnormal_foam_cell | 1.03606650 |
103 | MP0000955_abnormal_spinal_cord | 1.03051989 |
104 | MP0002060_abnormal_skin_morphology | 1.03023194 |
105 | MP0002398_abnormal_bone_marrow | 1.00051806 |
106 | MP0005075_abnormal_melanosome_morpholog | 0.99808506 |
107 | MP0003879_abnormal_hair_cell | 0.99352371 |
108 | MP0001502_abnormal_circadian_rhythm | 0.98650860 |
109 | MP0004883_abnormal_blood_vessel | 0.97749151 |
110 | MP0002254_reproductive_system_inflammat | 0.96962419 |
111 | MP0002928_abnormal_bile_duct | 0.94089397 |
112 | MP0002148_abnormal_hypersensitivity_rea | 0.94080878 |
113 | MP0005025_abnormal_response_to | 0.93764289 |
114 | MP0005390_skeleton_phenotype | 0.93736417 |
115 | MP0002138_abnormal_hepatobiliary_system | 0.92436392 |
116 | MP0001664_abnormal_digestion | 0.92018670 |
117 | MP0001853_heart_inflammation | 0.91068026 |
118 | MP0009931_abnormal_skin_appearance | 0.91064139 |
119 | MP0005464_abnormal_platelet_physiology | 0.90245692 |
120 | MP0005023_abnormal_wound_healing | 0.90012879 |
121 | MP0005164_abnormal_response_to | 0.88029261 |
122 | MP0000716_abnormal_immune_system | 0.86647605 |
123 | MP0002882_abnormal_neuron_morphology | 0.86577747 |
124 | MP0002909_abnormal_adrenal_gland | 0.85896156 |
125 | MP0002796_impaired_skin_barrier | 0.85891418 |
126 | MP0003656_abnormal_erythrocyte_physiolo | 0.84340812 |
127 | MP0002166_altered_tumor_susceptibility | 0.82399953 |
128 | MP0002638_abnormal_pupillary_reflex | 0.81341953 |
129 | MP0009764_decreased_sensitivity_to | 0.79172050 |
130 | MP0003448_altered_tumor_morphology | 0.79131012 |
131 | MP0001873_stomach_inflammation | 0.78777002 |
132 | MP0002419_abnormal_innate_immunity | 0.77645532 |
133 | MP0004808_abnormal_hematopoietic_stem | 0.77408074 |
134 | MP0002095_abnormal_skin_pigmentation | 0.75915918 |
135 | MP0008004_abnormal_stomach_pH | 0.75563682 |
136 | MP0000465_gastrointestinal_hemorrhage | 0.74439175 |
137 | MP0001849_ear_inflammation | 0.73513971 |
138 | MP0002066_abnormal_motor_capabilities/c | 0.71920784 |
139 | MP0000703_abnormal_thymus_morphology | 0.71840498 |
140 | MP0006054_spinal_hemorrhage | 0.70623345 |
141 | MP0004185_abnormal_adipocyte_glucose | 0.70321176 |
142 | MP0008874_decreased_physiological_sensi | 0.69860093 |
143 | MP0003795_abnormal_bone_structure | 0.68821194 |
144 | MP0010771_integument_phenotype | 0.68768611 |
145 | MP0000767_abnormal_smooth_muscle | 0.68252193 |
146 | MP0004264_abnormal_extraembryonic_tissu | 0.67420293 |
147 | MP0004142_abnormal_muscle_tone | 0.65397848 |
148 | MP0004381_abnormal_hair_follicle | 0.65086120 |
149 | MP0002751_abnormal_autonomic_nervous | 0.64907874 |
150 | MP0009763_increased_sensitivity_to | 0.64844199 |
151 | MP0000249_abnormal_blood_vessel | 0.64611777 |
152 | MP0002152_abnormal_brain_morphology | 0.64389115 |
153 | MP0001663_abnormal_digestive_system | 0.64130104 |
154 | MP0010155_abnormal_intestine_physiology | 0.63465325 |
155 | MP0005621_abnormal_cell_physiology | 0.63396155 |
156 | MP0009379_abnormal_foot_pigmentation | 0.62832593 |
157 | MP0006082_CNS_inflammation | 0.61243194 |
158 | MP0003091_abnormal_cell_migration | 0.60635979 |
159 | MP0008872_abnormal_physiological_respon | 0.60552864 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 4.61208203 |
2 | Abnormality of nail color (HP:0100643) | 4.56066470 |
3 | Pustule (HP:0200039) | 4.11540764 |
4 | Abnormality of macrophages (HP:0004311) | 3.99078593 |
5 | Focal motor seizures (HP:0011153) | 3.92178205 |
6 | Focal seizures (HP:0007359) | 3.86866856 |
7 | Limb dystonia (HP:0002451) | 3.65354152 |
8 | Increased IgE level (HP:0003212) | 3.46059226 |
9 | Abnormal hair whorl (HP:0010721) | 3.42738305 |
10 | Visual hallucinations (HP:0002367) | 3.37263925 |
11 | Recurrent skin infections (HP:0001581) | 3.31275667 |
12 | Febrile seizures (HP:0002373) | 3.22818030 |
13 | Spontaneous hematomas (HP:0007420) | 3.17246991 |
14 | Supranuclear gaze palsy (HP:0000605) | 3.13626862 |
15 | Gastrointestinal infarctions (HP:0005244) | 3.11081518 |
16 | Parakeratosis (HP:0001036) | 3.04334430 |
17 | Progressive inability to walk (HP:0002505) | 2.93216323 |
18 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.91424328 |
19 | Colitis (HP:0002583) | 2.81264696 |
20 | Gangrene (HP:0100758) | 2.79376514 |
21 | Urticaria (HP:0001025) | 2.78069706 |
22 | Chronic otitis media (HP:0000389) | 2.77657834 |
23 | Thick nail (HP:0001805) | 2.76902712 |
24 | Gingivitis (HP:0000230) | 2.74069209 |
25 | Atonic seizures (HP:0010819) | 2.63390844 |
26 | Agammaglobulinemia (HP:0004432) | 2.61386554 |
27 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.60776672 |
28 | Keratoconjunctivitis sicca (HP:0001097) | 2.60374642 |
29 | T lymphocytopenia (HP:0005403) | 2.59159245 |
30 | Failure to thrive in infancy (HP:0001531) | 2.58322937 |
31 | Epileptic encephalopathy (HP:0200134) | 2.56994704 |
32 | Palmoplantar hyperkeratosis (HP:0000972) | 2.55691337 |
33 | Progressive cerebellar ataxia (HP:0002073) | 2.55111812 |
34 | Hypoventilation (HP:0002791) | 2.54415654 |
35 | Mutism (HP:0002300) | 2.51314555 |
36 | Abnormality of binocular vision (HP:0011514) | 2.50447618 |
37 | Diplopia (HP:0000651) | 2.50447618 |
38 | Pulmonary infiltrates (HP:0002113) | 2.48933008 |
39 | Chest pain (HP:0100749) | 2.47617809 |
40 | Encephalitis (HP:0002383) | 2.42827410 |
41 | Sepsis (HP:0100806) | 2.42499916 |
42 | Epistaxis (HP:0000421) | 2.42381463 |
43 | Abnormality of T cell number (HP:0011839) | 2.40356589 |
44 | Hemoptysis (HP:0002105) | 2.35773052 |
45 | Keratoconjunctivitis (HP:0001096) | 2.35070628 |
46 | Dysostosis multiplex (HP:0000943) | 2.34960190 |
47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.32409540 |
48 | Palmar hyperkeratosis (HP:0010765) | 2.32293155 |
49 | Akinesia (HP:0002304) | 2.31230084 |
50 | Emphysema (HP:0002097) | 2.30550351 |
51 | Peritonitis (HP:0002586) | 2.27613278 |
52 | Skin ulcer (HP:0200042) | 2.27307635 |
53 | Truncal ataxia (HP:0002078) | 2.27057817 |
54 | Panhypogammaglobulinemia (HP:0003139) | 2.24968503 |
55 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.21883200 |
56 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.21524070 |
57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.20350964 |
58 | Obstructive lung disease (HP:0006536) | 2.20350964 |
59 | Lymphopenia (HP:0001888) | 2.19211689 |
60 | Open mouth (HP:0000194) | 2.17213192 |
61 | Abnormality of T cells (HP:0002843) | 2.16898610 |
62 | Eczematoid dermatitis (HP:0000976) | 2.15162994 |
63 | Recurrent fungal infections (HP:0002841) | 2.14885176 |
64 | Peripheral hypomyelination (HP:0007182) | 2.13654068 |
65 | Chronic sinusitis (HP:0011109) | 2.13334538 |
66 | Plantar hyperkeratosis (HP:0007556) | 2.12732793 |
67 | Myokymia (HP:0002411) | 2.12520249 |
68 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.12467184 |
69 | Gingival bleeding (HP:0000225) | 2.11467878 |
70 | Absence seizures (HP:0002121) | 2.07600929 |
71 | Osteomyelitis (HP:0002754) | 2.07438060 |
72 | Meningitis (HP:0001287) | 2.06019350 |
73 | Hypoplasia of the brainstem (HP:0002365) | 2.04438219 |
74 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.04438219 |
75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04119581 |
76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04119581 |
77 | Recurrent abscess formation (HP:0002722) | 2.03843533 |
78 | Exotropia (HP:0000577) | 2.03412245 |
79 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.03378532 |
80 | Cellulitis (HP:0100658) | 2.02154182 |
81 | Gastrointestinal stroma tumor (HP:0100723) | 2.02060588 |
82 | Abnormality of T cell physiology (HP:0011840) | 2.00401032 |
83 | Myositis (HP:0100614) | 1.99315199 |
84 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97246486 |
85 | Granulocytopenia (HP:0001913) | 1.96859348 |
86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95923940 |
87 | Increased cerebral lipofuscin (HP:0011813) | 1.95226078 |
88 | Viral hepatitis (HP:0006562) | 1.94575304 |
89 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.92845512 |
90 | Hypochromic anemia (HP:0001931) | 1.92226607 |
91 | Polyphagia (HP:0002591) | 1.91800422 |
92 | Morphological abnormality of the middle ear (HP:0008609) | 1.91097319 |
93 | Broad face (HP:0000283) | 1.90960311 |
94 | Amblyopia (HP:0000646) | 1.90546609 |
95 | Arterial thrombosis (HP:0004420) | 1.90026240 |
96 | Slow saccadic eye movements (HP:0000514) | 1.89961843 |
97 | Petechiae (HP:0000967) | 1.89733193 |
98 | Submucous cleft hard palate (HP:0000176) | 1.89566377 |
99 | Generalized tonic-clonic seizures (HP:0002069) | 1.89475040 |
100 | Mediastinal lymphadenopathy (HP:0100721) | 1.88919601 |
101 | Narrow nasal bridge (HP:0000446) | 1.87015459 |
102 | Inability to walk (HP:0002540) | 1.86959117 |
103 | Leukocytosis (HP:0001974) | 1.85677769 |
104 | Mucopolysacchariduria (HP:0008155) | 1.85101231 |
105 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85101231 |
106 | Dilatation of the ascending aorta (HP:0005111) | 1.84446408 |
107 | Interstitial pulmonary disease (HP:0006530) | 1.84192071 |
108 | Broad-based gait (HP:0002136) | 1.83691565 |
109 | Premature loss of primary teeth (HP:0006323) | 1.82008930 |
110 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81372489 |
111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81372489 |
112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81372489 |
113 | Inflammation of the large intestine (HP:0002037) | 1.81040425 |
114 | Pulmonary embolism (HP:0002204) | 1.80835340 |
115 | Episodic fever (HP:0001954) | 1.80676934 |
116 | Restrictive lung disease (HP:0002091) | 1.80476654 |
117 | Ulnar claw (HP:0001178) | 1.80407297 |
118 | Nasal polyposis (HP:0100582) | 1.80382484 |
119 | Recurrent viral infections (HP:0004429) | 1.80277275 |
120 | Inappropriate behavior (HP:0000719) | 1.80210483 |
121 | Stereotypic behavior (HP:0000733) | 1.79094478 |
122 | Abnormality of the fingertips (HP:0001211) | 1.77532116 |
123 | Vasculitis (HP:0002633) | 1.77420662 |
124 | Lower limb amyotrophy (HP:0007210) | 1.77412982 |
125 | Ectropion (HP:0000656) | 1.77201398 |
126 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.76933129 |
127 | Hypergammaglobulinemia (HP:0010702) | 1.76718654 |
128 | Obstructive sleep apnea (HP:0002870) | 1.76554797 |
129 | Spondylolisthesis (HP:0003302) | 1.76309312 |
130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.75618043 |
131 | Anorexia (HP:0002039) | 1.75500708 |
132 | Hypotrichosis (HP:0001006) | 1.74969083 |
133 | Malnutrition (HP:0004395) | 1.74324959 |
134 | Agitation (HP:0000713) | 1.74237209 |
135 | Generalized hypopigmentation of hair (HP:0011358) | 1.73947432 |
136 | Loss of speech (HP:0002371) | 1.73918078 |
137 | Abnormal blistering of the skin (HP:0008066) | 1.73795745 |
138 | Recurrent bronchitis (HP:0002837) | 1.73789313 |
139 | Orchitis (HP:0100796) | 1.73439422 |
140 | Genetic anticipation (HP:0003743) | 1.72364383 |
141 | Hemiparesis (HP:0001269) | 1.70987943 |
142 | Gastrointestinal inflammation (HP:0004386) | 1.70581608 |
143 | Retrobulbar optic neuritis (HP:0100654) | 1.70265518 |
144 | Optic neuritis (HP:0100653) | 1.70265518 |
145 | Erythema (HP:0010783) | 1.68423463 |
146 | Absent eyebrow (HP:0002223) | 1.67165467 |
147 | Hypercortisolism (HP:0001578) | 1.66608342 |
148 | Dialeptic seizures (HP:0011146) | 1.66161255 |
149 | Recurrent sinusitis (HP:0011108) | 1.65518789 |
150 | Excessive salivation (HP:0003781) | 1.65512880 |
151 | Drooling (HP:0002307) | 1.65512880 |
152 | Increased IgM level (HP:0003496) | 1.64538377 |
153 | Cheilitis (HP:0100825) | 1.64223584 |
154 | Verrucae (HP:0200043) | 1.63204911 |
155 | Papilloma (HP:0012740) | 1.63204911 |
156 | Stomatitis (HP:0010280) | 1.62300429 |
157 | Prolonged bleeding time (HP:0003010) | 1.62293586 |
158 | Aplasia cutis congenita (HP:0001057) | 1.60874984 |
159 | Poor suck (HP:0002033) | 1.60305656 |
160 | Generalized hypopigmentation (HP:0007513) | 1.60027535 |
161 | Generalized hypotonia (HP:0001290) | 1.59624034 |
162 | Fetal akinesia sequence (HP:0001989) | 1.59388932 |
163 | Hemiplegia (HP:0002301) | 1.58602958 |
164 | Abnormality of the nasal mucosa (HP:0000433) | 1.57778739 |
165 | Iris hypopigmentation (HP:0007730) | 1.57497059 |
166 | Tented upper lip vermilion (HP:0010804) | 1.55701749 |
167 | Popliteal pterygium (HP:0009756) | 1.55378602 |
168 | Sparse scalp hair (HP:0002209) | 1.54501123 |
169 | Depression (HP:0000716) | 1.54341479 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MARK1 | 3.70470441 |
2 | SIK2 | 3.65004880 |
3 | MAP3K9 | 3.23663549 |
4 | ERN1 | 3.14972767 |
5 | MAP2K3 | 2.85022319 |
6 | PRPF4B | 2.80975706 |
7 | IRAK4 | 2.63670335 |
8 | EEF2K | 2.42419913 |
9 | RIPK4 | 2.37512693 |
10 | NTRK3 | 2.32672131 |
11 | TRIB3 | 2.29659204 |
12 | CASK | 2.15563668 |
13 | MAP4K1 | 2.14043492 |
14 | BLK | 2.13213088 |
15 | MAPK13 | 2.08869034 |
16 | TNIK | 2.07084718 |
17 | MAP2K7 | 2.04729660 |
18 | MAP3K12 | 1.98286242 |
19 | FES | 1.98183378 |
20 | MAP3K4 | 1.91234806 |
21 | NTRK2 | 1.90494649 |
22 | SIK3 | 1.81116749 |
23 | MAP3K3 | 1.75904546 |
24 | MAP3K13 | 1.69810451 |
25 | KSR2 | 1.51699290 |
26 | SYK | 1.50525858 |
27 | TXK | 1.50300139 |
28 | SIK1 | 1.45046342 |
29 | RET | 1.42791247 |
30 | GRK6 | 1.41353049 |
31 | MINK1 | 1.31169383 |
32 | CDC42BPA | 1.28714742 |
33 | MARK2 | 1.28280354 |
34 | SMG1 | 1.23709216 |
35 | RAF1 | 1.21321237 |
36 | JAK3 | 1.20871409 |
37 | GRK5 | 1.18943831 |
38 | EPHA2 | 1.17580599 |
39 | ZAP70 | 1.16514925 |
40 | CDK12 | 1.14025998 |
41 | CSF1R | 1.11937814 |
42 | IKBKE | 1.08757202 |
43 | MAP3K11 | 1.07588873 |
44 | HCK | 1.06942932 |
45 | MARK3 | 1.06499260 |
46 | FGR | 1.06375322 |
47 | PLK2 | 1.05984052 |
48 | TBK1 | 1.00923126 |
49 | MAP3K14 | 0.97909279 |
50 | STK10 | 0.97321339 |
51 | PTK6 | 0.97221207 |
52 | TAOK3 | 0.96870721 |
53 | MAP3K7 | 0.95677083 |
54 | DMPK | 0.91833104 |
55 | TEC | 0.90840778 |
56 | PAK6 | 0.90344841 |
57 | KSR1 | 0.90126881 |
58 | JAK2 | 0.87649730 |
59 | MAP3K10 | 0.84839586 |
60 | PTK2B | 0.84597370 |
61 | KIT | 0.84419366 |
62 | IRAK3 | 0.83856106 |
63 | CDK5 | 0.83199882 |
64 | TAOK2 | 0.82406972 |
65 | MAP2K4 | 0.82176262 |
66 | CAMKK1 | 0.81660055 |
67 | CSNK1G2 | 0.80703534 |
68 | FGFR3 | 0.80650543 |
69 | FGFR4 | 0.80561941 |
70 | PKN1 | 0.80319932 |
71 | IRAK1 | 0.79268119 |
72 | BMX | 0.77514271 |
73 | ITK | 0.77453010 |
74 | PDK1 | 0.76244471 |
75 | LCK | 0.75746873 |
76 | IRAK2 | 0.74159182 |
77 | MAP3K2 | 0.73004028 |
78 | HIPK2 | 0.72688920 |
79 | MAPK7 | 0.71704881 |
80 | RPS6KA2 | 0.71127750 |
81 | YES1 | 0.70660876 |
82 | RIPK1 | 0.70195953 |
83 | CDK19 | 0.68522808 |
84 | PDPK1 | 0.68029851 |
85 | TTN | 0.66053473 |
86 | CAMK1G | 0.65403222 |
87 | MAPKAPK5 | 0.64940397 |
88 | TNK2 | 0.64497925 |
89 | TAOK1 | 0.64308366 |
90 | ICK | 0.63745023 |
91 | EPHB1 | 0.62030893 |
92 | CLK1 | 0.62007295 |
93 | PDGFRB | 0.61529062 |
94 | DAPK2 | 0.60828307 |
95 | JAK1 | 0.60792049 |
96 | PHKG2 | 0.60365751 |
97 | PHKG1 | 0.60365751 |
98 | DYRK2 | 0.59609604 |
99 | MAPK12 | 0.59561892 |
100 | PNCK | 0.59090442 |
101 | LRRK2 | 0.58866883 |
102 | CSK | 0.58809526 |
103 | CSNK1G3 | 0.58340132 |
104 | FYN | 0.57537731 |
105 | BMPR2 | 0.56944249 |
106 | NLK | 0.56689128 |
107 | TLK1 | 0.56599181 |
108 | RPS6KC1 | 0.55469403 |
109 | RPS6KL1 | 0.55469403 |
110 | EPHA3 | 0.54832310 |
111 | BTK | 0.54823783 |
112 | DYRK1B | 0.54040095 |
113 | CHUK | 0.52509842 |
114 | PRKCH | 0.52058973 |
115 | MST4 | 0.51857340 |
116 | PAK3 | 0.50762771 |
117 | LYN | 0.50372118 |
118 | LATS2 | 0.49674103 |
119 | TGFBR2 | 0.49171196 |
120 | IKBKB | 0.49103679 |
121 | PDGFRA | 0.48285498 |
122 | GRK7 | 0.47981814 |
123 | MELK | 0.47048519 |
124 | TYK2 | 0.46975757 |
125 | PRKD2 | 0.46345160 |
126 | SGK3 | 0.45414381 |
127 | MAP3K1 | 0.44990971 |
128 | RPS6KA6 | 0.43215183 |
129 | MAPK11 | 0.42791746 |
130 | NTRK1 | 0.41454082 |
131 | PIK3CG | 0.41339943 |
132 | MAPKAPK2 | 0.39676917 |
133 | MAP3K6 | 0.39476091 |
134 | PIM1 | 0.39413728 |
135 | ADRBK1 | 0.39317065 |
136 | STK38 | 0.39068951 |
137 | WNK1 | 0.38579702 |
138 | MTOR | 0.38240485 |
139 | PKN2 | 0.37282393 |
140 | STK11 | 0.37133065 |
141 | PRKCQ | 0.36666361 |
142 | ALK | 0.35771472 |
143 | CDK4 | 0.35387935 |
144 | CAMK1 | 0.34881768 |
145 | MAP2K2 | 0.33515825 |
146 | TYRO3 | 0.32889910 |
147 | MAP2K6 | 0.32218368 |
148 | MAP2K1 | 0.32023582 |
149 | MATK | 0.31863211 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.25592753 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.17949042 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92926355 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.87551136 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.84818906 |
6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59376926 |
7 | Influenza A_Homo sapiens_hsa05164 | 1.43584569 |
8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.41899571 |
9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40396030 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39680342 |
11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.39645908 |
12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37414258 |
13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.35628100 |
14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.34641809 |
15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33925788 |
16 | Morphine addiction_Homo sapiens_hsa05032 | 1.32950148 |
17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31425982 |
18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30434390 |
19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.29931345 |
20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28562443 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28185032 |
22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27387832 |
23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26424867 |
24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.26036443 |
25 | Malaria_Homo sapiens_hsa05144 | 1.25998856 |
26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25109563 |
27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.22019810 |
28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.20934526 |
29 | Long-term depression_Homo sapiens_hsa04730 | 1.20216304 |
30 | Taste transduction_Homo sapiens_hsa04742 | 1.17492186 |
31 | Axon guidance_Homo sapiens_hsa04360 | 1.16331314 |
32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.15136506 |
33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.14645419 |
34 | Hepatitis C_Homo sapiens_hsa05160 | 1.14506795 |
35 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12085578 |
36 | Olfactory transduction_Homo sapiens_hsa04740 | 1.10239490 |
37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08644800 |
38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07571350 |
39 | Salivary secretion_Homo sapiens_hsa04970 | 1.07313160 |
40 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.07198905 |
41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.07043937 |
42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06531270 |
43 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04911759 |
44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04907034 |
45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04489068 |
46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04311323 |
47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03722286 |
48 | GABAergic synapse_Homo sapiens_hsa04727 | 1.03682388 |
49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02288091 |
50 | Asthma_Homo sapiens_hsa05310 | 1.02190257 |
51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.01961469 |
52 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.01022152 |
53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00958228 |
54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00584262 |
55 | Shigellosis_Homo sapiens_hsa05131 | 1.00155389 |
56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99715520 |
57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99559661 |
58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.99291156 |
59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98944401 |
60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98896261 |
61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.98530270 |
62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.97027448 |
63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97003785 |
64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.96826017 |
65 | Glioma_Homo sapiens_hsa05214 | 0.95984082 |
66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95575771 |
67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95122080 |
68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94335885 |
69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94072310 |
70 | Renin secretion_Homo sapiens_hsa04924 | 0.93524883 |
71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92842130 |
72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.90479109 |
73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89889219 |
74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89377128 |
75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89175459 |
76 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89004355 |
77 | Apoptosis_Homo sapiens_hsa04210 | 0.88806025 |
78 | Lysosome_Homo sapiens_hsa04142 | 0.88764593 |
79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88268241 |
80 | Platelet activation_Homo sapiens_hsa04611 | 0.88137190 |
81 | Allograft rejection_Homo sapiens_hsa05330 | 0.87829748 |
82 | Endocytosis_Homo sapiens_hsa04144 | 0.87388003 |
83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86733737 |
84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86123277 |
85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86009965 |
86 | Pertussis_Homo sapiens_hsa05133 | 0.85491859 |
87 | Tuberculosis_Homo sapiens_hsa05152 | 0.84313167 |
88 | Insulin secretion_Homo sapiens_hsa04911 | 0.83750822 |
89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83701501 |
90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83608042 |
91 | Gap junction_Homo sapiens_hsa04540 | 0.83469501 |
92 | Measles_Homo sapiens_hsa05162 | 0.83345634 |
93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82647203 |
94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81166688 |
95 | Legionellosis_Homo sapiens_hsa05134 | 0.80304049 |
96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80292595 |
97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79946445 |
98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79334138 |
99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78766527 |
100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78615646 |
101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78189489 |
102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76836825 |
103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.76349233 |
104 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.75952308 |
105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75678455 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75041177 |
107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74639079 |
108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74618336 |
109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74586373 |
110 | Amoebiasis_Homo sapiens_hsa05146 | 0.74467994 |
111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74011048 |
112 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.73006456 |
113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71852616 |
114 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71535453 |
115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71080851 |
116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70940807 |
117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70201042 |
118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69963769 |
119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69873724 |
120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69022058 |
121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68872220 |
122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68584180 |
123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67933668 |
124 | Melanogenesis_Homo sapiens_hsa04916 | 0.67527415 |
125 | Hepatitis B_Homo sapiens_hsa05161 | 0.67487277 |
126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67095822 |
127 | Salmonella infection_Homo sapiens_hsa05132 | 0.66395675 |
128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66158484 |
129 | Phagosome_Homo sapiens_hsa04145 | 0.65047610 |
130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64227657 |
131 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62311044 |
132 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58743578 |
133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57659981 |
134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57416317 |
135 | Insulin resistance_Homo sapiens_hsa04931 | 0.56577128 |
136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55693499 |
137 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54189908 |
138 | Prostate cancer_Homo sapiens_hsa05215 | 0.53745515 |
139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51719217 |
140 | Focal adhesion_Homo sapiens_hsa04510 | 0.51074055 |
141 | Bladder cancer_Homo sapiens_hsa05219 | 0.50459200 |
142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49412582 |